Contact Us

The Ophthalmologist Article The Need for Speed by Jeanne Hecht and David Almeida

The Need for Speed: Why vertical integration is the key to streamlining complex retina clinical trials

Read Full Article

Eyes on Eyecare Article by David Tanzer, MD and Nevin El-Nimri, OD, PhD. BCVA: Still the Gold Standard for Clinical Trials

Best Corrected Visual Acuity: Still the Gold Standard in Clinical Trials—But for How Long?

Lexitas and NAMSA announce strategic partnership for ophthalmic medical device development

Lexitas and NAMSA Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development

Meet Lexitas at EURETINA in Vienna

EURETINA

Additional Resources

The Ophthalmologist Article The Need for Speed by Jeanne Hecht and David Almeida

The Need for Speed: Why vertical integration is the key to streamlining complex retina clinical trials

Eyes on Eyecare Article by David Tanzer, MD and Nevin El-Nimri, OD, PhD. BCVA: Still the Gold Standard for Clinical Trials

Best Corrected Visual Acuity: Still the Gold Standard in Clinical Trials—But for How Long?

Lexitas Ophthalmology CRO added to Octane Preferred Advisors

Octane Welcomes Lexitas Pharma Services as Newest Octane Preferred Advisor

Lexitas Announces Acquisition of Erie Retina Research

Lexitas Pharma Services Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie

Lexitas and NAMSA announce strategic partnership for ophthalmic medical device development

Lexitas and NAMSA Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development

Cell & Gene Therapy in Ophthalmology

Webinar: Cell & Gene Therapy in Ophthalmology